NSI-189: A Novel Neurogenic Compound for Depression and Cognitive Enhancement

Explore the potential of NSI-189, a cutting-edge pharmaceutical intermediate designed to address major depressive disorder and cognitive decline. Discover its benefits as a reliable supplier in China.

Get a Quote & Sample

Product Advantages

Neurogenesis Stimulation

NSI-189 is recognized for its ability to stimulate neurogenesis, supporting the growth of new brain cells, which is crucial for addressing conditions like cognitive impairment.

Antidepressant Efficacy

This compound demonstrates significant potential as an antidepressant, offering a new avenue for treating major depressive disorder by targeting underlying neurological mechanisms.

Cognitive Improvement

NSI-189 offers procognitive benefits, including improved memory and learning capabilities, making it a valuable pharmaceutical intermediate for cognitive enhancement research.

Key Applications

Mental Health Treatment

As a potent NSI-189 antidepressant, this compound is vital for developing treatments for major depressive disorder and other mood-related conditions.

Cognitive Support

Leverage NSI-189's procognitive effects to improve memory and learning, supporting applications in cognitive enhancement and brain health.

Neurodegenerative Disease Research

The neurogenesis stimulation provided by NSI-189 is key for research into treatments for neurodegenerative diseases, promoting brain cell repair.

Pharmaceutical Research and Development

As a high-purity pharmaceutical intermediate, NSI-189 is essential for R&D in central nervous system therapeutics.